Market Overview:
The global human ELISA kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for human ELISA kits from hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and research institutes across the globe. Additionally, factors such as technological advancements and rising awareness about various diseases are also contributing to the growth of this market. On the basis of type, unconjugated ELISA kits held a major share of the global human ELISA kits market in 2017. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 owing to its high accuracy and reliability levels compared with other types of ELISA kits available in the market.
Product Definition:
Human ELISA Kits are used to detect and measure the amount of human immunoglobulin in a sample. The kits can be used to determine if someone has been infected with a virus, or to monitor the progress of an infection or treatment.
Unconjugated:
Unconjugated antibodies are those that remain attached to the antigen they are raised against. They can be used in immunoassays but need a secondary antibody for detection and purification. Unconjugated antibodies have several advantages over conventional ones, such as greater specificity, no requirement of radioisotopes or conjugates and higher affinity (2x - 10x).
Alkaline Phosphatase:
Alkaline phosphatase is an enzyme that catalyzes the hydrolysis of particular phosphate esters to form acid and alcohol. It is used as a substrate in immunoassay procedures where it specifically lights up on alkaline phosphatase test paper.
Application Insights:
The research institutes segment dominated the global human ELISA kits market in 2017. This can be attributed to the rising number of R&D activities being carried out worldwide for developing new drugs and diagnostics. For instance, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), in 2018 PhRMA member biopharmaceutical research companies have invested around USD 79 billion for discovery & development as well as commercialization of novel medicines and other therapies.
This investment is expected to yield around 13 new medicines by 2030 with an estimated value of over USD cap each which would drive demand further during that period. In addition, growing government funding for medical research along with increasing R&D productivity are anticipated to augment industry growth during the forecast period.
Regional Analysis:
North America dominated the global human ELISA kits market in 2017. This is due to the presence of a large number of biotechnology and pharmaceutical companies, which are engaged in R&D activities for new drug development. Moreover, increasing government funding for such research activities is also expected to drive regional growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments and private sectors as well as growing interest of foreign investors in this region due to availability of skilled labor at low cost coupled with easy access to resources required for drug discovery & development process. These factors are expected contribute towards rapid expansion of laboratories & diagnostic centers and increase spending on R&D by biopharmaceutical & pharmaceutical companies operating within this region thus driving demand over next eight years.
Growth Factors:
- Increasing demand for human ELISA kits from biotechnology and pharmaceutical industries for drug development and research purposes.
- Growing prevalence of target diseases that can be diagnosed through ELISA tests, such as cancer, HIV/AIDS, tuberculosis, etc.
- Technological advancements in ELISA assay techniques that are resulting in more sensitive and specific tests kits.
- Rising demand for personalized medicine and companion diagnostics that rely on accurate diagnostic testing methods like ELISA assays
Scope Of The Report
Report Attributes
Report Details
Report Title
Human ELISA Kits Market Research Report
By Type
Unconjugated, Alkaline Phosphatase, Biotin, Others
By Application
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
By Companies
Abbexa Ltd, Abcam, Abnova Corporation, Antibodies-online, Antigenix America Inc., Aviva Systems Biology, Bioassay Technology Laboratory, Biomatik, Biorbyt, BioVision, BosterBio, Cell Signaling Technology, Cellular Technology Limited, Creative Diagnostics, CUSABIO Technology LLC, DLdevelop, Elabscience Biotechnology Inc., G Biosciences, GenWay Biotech, Inc., LifeSpan BioSciences, MyBioSource.com, Nordic BioSite, Novus Biologicals, OriGene Technologies, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Human ELISA Kits Market Report Segments:
The global Human ELISA Kits market is segmented on the basis of:
Types
Unconjugated, Alkaline Phosphatase, Biotin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbexa Ltd
- Abcam
- Abnova Corporation
- Antibodies-online
- Antigenix America Inc.
- Aviva Systems Biology
- Bioassay Technology Laboratory
- Biomatik
- Biorbyt
- BioVision
- BosterBio
- Cell Signaling Technology
- Cellular Technology Limited
- Creative Diagnostics
- CUSABIO Technology LLC
- DLdevelop
- Elabscience Biotechnology Inc.
- G Biosciences
- GenWay Biotech, Inc.
- LifeSpan BioSciences
- MyBioSource.com
- Nordic BioSite
- Novus Biologicals
- OriGene Technologies
- Thermo Fisher Scientific
Highlights of The Human ELISA Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Unconjugated
- Alkaline Phosphatase
- Biotin
- Others
- By Application:
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human ELISA Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human ELISA Kits are used to detect the presence of specific human proteins in a sample.
Some of the major players in the human elisa kits market are Abbexa Ltd, Abcam, Abnova Corporation, Antibodies-online, Antigenix America Inc., Aviva Systems Biology, Bioassay Technology Laboratory, Biomatik, Biorbyt, BioVision, BosterBio, Cell Signaling Technology, Cellular Technology Limited, Creative Diagnostics, CUSABIO Technology LLC, DLdevelop, Elabscience Biotechnology Inc., G Biosciences, GenWay Biotech, Inc., LifeSpan BioSciences, MyBioSource.com, Nordic BioSite, Novus Biologicals, OriGene Technologies, Thermo Fisher Scientific.
The human elisa kits market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human ELISA Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human ELISA Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human ELISA Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human ELISA Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human ELISA Kits Market Size & Forecast, 2018-2028
4.5.1 Human ELISA Kits Market Size and Y-o-Y Growth
4.5.2 Human ELISA Kits Market Absolute $ Opportunity
Chapter 5 Global Human ELISA Kits Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Human ELISA Kits Market Size Forecast by Type
5.2.1 Unconjugated
5.2.2 Alkaline Phosphatase
5.2.3 Biotin
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Human ELISA Kits Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Human ELISA Kits Market Size Forecast by Applications
6.2.1 Hospitals & Diagnostic Laboratories
6.2.2 Pharmaceutical & Biotechnology
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human ELISA Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human ELISA Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Human ELISA Kits Analysis and Forecast
9.1 Introduction
9.2 North America Human ELISA Kits Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Human ELISA Kits Market Size Forecast by Type
9.6.1 Unconjugated
9.6.2 Alkaline Phosphatase
9.6.3 Biotin
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Human ELISA Kits Market Size Forecast by Applications
9.10.1 Hospitals & Diagnostic Laboratories
9.10.2 Pharmaceutical & Biotechnology
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Human ELISA Kits Analysis and Forecast
10.1 Introduction
10.2 Europe Human ELISA Kits Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Human ELISA Kits Market Size Forecast by Type
10.6.1 Unconjugated
10.6.2 Alkaline Phosphatase
10.6.3 Biotin
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Human ELISA Kits Market Size Forecast by Applications
10.10.1 Hospitals & Diagnostic Laboratories
10.10.2 Pharmaceutical & Biotechnology
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Human ELISA Kits Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Human ELISA Kits Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Human ELISA Kits Market Size Forecast by Type
11.6.1 Unconjugated
11.6.2 Alkaline Phosphatase
11.6.3 Biotin
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Human ELISA Kits Market Size Forecast by Applications
11.10.1 Hospitals & Diagnostic Laboratories
11.10.2 Pharmaceutical & Biotechnology
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Human ELISA Kits Analysis and Forecast
12.1 Introduction
12.2 Latin America Human ELISA Kits Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Human ELISA Kits Market Size Forecast by Type
12.6.1 Unconjugated
12.6.2 Alkaline Phosphatase
12.6.3 Biotin
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Human ELISA Kits Market Size Forecast by Applications
12.10.1 Hospitals & Diagnostic Laboratories
12.10.2 Pharmaceutical & Biotechnology
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Human ELISA Kits Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Human ELISA Kits Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Human ELISA Kits Market Size Forecast by Type
13.6.1 Unconjugated
13.6.2 Alkaline Phosphatase
13.6.3 Biotin
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Human ELISA Kits Market Size Forecast by Applications
13.10.1 Hospitals & Diagnostic Laboratories
13.10.2 Pharmaceutical & Biotechnology
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human ELISA Kits Market: Competitive Dashboard
14.2 Global Human ELISA Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbexa Ltd
14.3.2 Abcam
14.3.3 Abnova Corporation
14.3.4 Antibodies-online
14.3.5 Antigenix America Inc.
14.3.6 Aviva Systems Biology
14.3.7 Bioassay Technology Laboratory
14.3.8 Biomatik
14.3.9 Biorbyt
14.3.10 BioVision
14.3.11 BosterBio
14.3.12 Cell Signaling Technology
14.3.13 Cellular Technology Limited
14.3.14 Creative Diagnostics
14.3.15 CUSABIO Technology LLC
14.3.16 DLdevelop
14.3.17 Elabscience Biotechnology Inc.
14.3.18 G Biosciences
14.3.19 GenWay Biotech, Inc.
14.3.20 LifeSpan BioSciences
14.3.21 MyBioSource.com
14.3.22 Nordic BioSite
14.3.23 Novus Biologicals
14.3.24 OriGene Technologies
14.3.25 Thermo Fisher Scientific
